Those important findings were also transferred to a retrospective progression-free-survival analysis stratified by COX-2 expression in 135 completely removed (Simpson grade I-III) intracranial WHO grade 1 and 2 meningiomas [34]. The gene discussed is PTGS2; the disease is meningioma.